Clinical

Genetics

Our expertise in clinical genetics has positioned us as a key partner in collaboration with a Harvard University spinoff. Together, we have embarked on a groundbreaking journey to develop and operate an AI-driven rapid analysis system for clinical genetic results, leveraging the invaluable input of human experts.

Through our collaboration, we have achieved remarkable progress.

Today, our client's platform facilitates the delivery of thousands of daily analyses of genetic variant information. This means that healthcare professionals and patients around the globe can access highly accurate and clinically relevant results in a timely manner, transforming the way genetic information is interpreted and utilized in medical practice.

Operating in a highly regulated environment, we recognize the criticality of maintaining the highest standards of quality and accuracy. Our team is dedicated to upholding these standards throughout every step of the process, ensuring that our client's platform consistently delivers trustworthy and reliable results. By combining advanced AI technology with human expertise, we have revolutionized the field of clinical genetics, empowering healthcare providers and improving patient outcomes on a global scale.

​

​

​

​

​

​

​

​

​

AI Driven Dementia Detection

Our client is committed to revolutionizing the field of dementia detection through the application of advanced technologies. With the aim of developing preventive and curative therapies, they have embraced the power of artificial intelligence (AI) in combination with human expertise to assess speech, video, and longitudinal biometric data. By augmenting their team with pre-trained AI models and incorporating human input, they are paving the way for groundbreaking discoveries in Alzheimer's and Parkinson's diseases.

​

Through the integration of AI and human expertise, our client is able to enhance their team's capabilities and unlock new insights. AI models, specifically designed for dementia detection, analyze vast amounts of data to identify patterns and correlations. However, the human element is crucial in interpreting the results and providing contextual understanding, ensuring the accuracy and reliability of the analysis. This collaborative approach holds great promise in improving predictive outcomes and advancing research in neurodegenerative disorders.

​

By leveraging the power of AI technology alongside the knowledge and experience of human specialists, our client is at the forefront of early dementia detection. Their innovative approach not only enables more accurate assessments but also provides valuable insights for the development of targeted therapies and interventions. Through this transformative integration of AI and human expertise, they are driving advancements in the field and making significant strides towards improving the lives of individuals affected by Alzheimer's and Parkinson's diseases.

​

Synthetic Biology Meets Synthetic AI

The promise of synthetic biology lies in the ability to program cells to perform specific functions, leading to significant advancements in various fields such as food production, decarbonization, sustainable materials, and medicine. Augment is at the forefront of this exciting field, building and operating a real-time platform that enables our clients to analyze millions of biology publications.

Our platform focuses on identifying correlations and causality within the intricate network of systems biology, particularly in the context of enhancing specific metabolic pathways. This involves the ingestion and analysis of scientific text, images, data, and recursive references to other publications. Throughout this process, our platform operates under the guidance and supervision of human experts who provide valuable insights to guide the analysis.

By harnessing the power of AI and human expertise, we strive to unlock new possibilities and drive innovation in the field of synthetic biology.

​

​

​

​

​

​

​

​

​

​

​

​

​